Association between a variant of the sigma-1 receptor gene and Alzheimer's disease

Neuroscience Letters
Agnes FehérZoltán Janka

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with complex etiology and strong genetic predisposition. A number of investigations support the possible involvement of sigma non-opioid intracellular receptor 1 (SIGMAR1) in the pathophysiology of AD. We aimed to investigate the association between SIGMAR1 polymorphisms and late-onset AD, therefore we genotyped rs1799729 (GC-241-240TT) and rs1800866 (Q2P) in 322 Hungarian late-onset AD patients and 250 ethnically matched, elderly control individuals. The investigated polymorphisms were in nearly complete linkage disequilibrium resulting in the GC-Q and TT-P predominant haplotypes that were subjected to the statistical analyses. Our data demonstrates an association between the SIGMAR1 TT-P variant and the risk for developing AD (p=0.019), and a potential modest interaction effect (p=0.058) of the co-presence of the TT-P haplotype with apolipoprotein E4 allele on the risk for AD. Based on this mild significance, we could not fully support the hypothesis that TT-P haplotype in interaction with APOE E4 allele confers risk for developing AD.

References

Jul 30, 2003·Neurobiology of Aging·Kazunori KawamuraKiichi Ishiwata
Jan 7, 2004·Biological Psychiatry·Ryosuke MiyatakeHiroshi Suwaki
Jul 14, 2005·Neuroreport·Agostino MarrazzoGiuseppe Ronsisvalle
Jul 26, 2005·Experimental Eye Research·George Duncan, Lixin Wang
Apr 26, 2007·Dementia and Geriatric Cognitive Disorders·Aleksandra MaruszakMaria Barcikowska
May 24, 2008·Annals of Nuclear Medicine·Masahiro MishinaKiichi Ishiwata
Dec 5, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Vanessa VillardTangui Maurice
Jul 22, 2009·Pharmacology & Therapeutics·Tangui Maurice, Tsung-Ping Su
Jan 12, 2010·Behavioural Brain Research·Aren van WaardeRudi A Dierckx
Feb 25, 2010·Neuropharmacology·Taro KishiNakao Iwata
Nov 4, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisDebby W Tsuang

❮ Previous
Next ❯

Citations

Oct 22, 2014·Expert Opinion on Therapeutic Targets·Shang-Yi A TsaiTsung-Ping Su
Jun 10, 2015·Journal of Receptor and Signal Transduction Research·Colin G Rousseaux, Stephanie F Greene
May 13, 2015·Proceedings of the National Academy of Sciences of the United States of America·Shang-Yi A TsaiTsung-Ping Su
Jul 29, 2016·Human Molecular Genetics·Michal GevaMichael R Hayden
Mar 16, 2019·Autophagy·Huan YangLian-Wang Guo
Sep 6, 2013·The Journal of Pharmacology and Experimental Therapeutics·Adam A BehenskyJavier Cuevas
Feb 15, 2020·Journal of Receptor and Signal Transduction Research·Michał Skrzycki, Beata Kaźmierczak
Apr 5, 2018·Journal of Alzheimer's Disease : JAD·Woojin Scott KimJohn B J Kwok
Sep 26, 2019·Frontiers in Neuroscience·Daniel A RyskampIlya Bezprozvanny
Oct 15, 2019·Frontiers in Neuroscience·Daniel A RyskampIlya Bezprozvanny
Nov 13, 2015·Molecular Pharmacology·Uyen B Chu, Arnold E Ruoho
Oct 9, 2018·Frontiers in Cellular Neuroscience·Jia JiaXuechu Zhen
Oct 24, 2020·Cellular and Molecular Neurobiology·Simon CoulyTsung-Ping Su
Dec 18, 2020·International Journal of Molecular Sciences·Fanny EysertMounia Chami
Dec 23, 2020·Journal of Neurochemistry·Hadjara SidibéChristine Vande Velde
Apr 4, 2015·Virus Research·Claudia Vasallo, Pablo Gastaminza
Apr 17, 2021·Genes & Development·Maja PetkovicYuh Nung Jan
Jul 3, 2021·International Journal of Molecular Sciences·Francesca Serena AbatematteoCarmen Abate
Jul 27, 2021·Frontiers in Physiology·Richa AishwaryaMd Shenuarin Bhuiyan
Aug 6, 2021·Pharmacological Reports : PR·Agnieszka PiechalDagmara Mirowska-Guzel
Oct 21, 2021·The FEBS Journal·Robert E Means, Samuel G Katz

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.